Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Friedman

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
Journal of the National Cancer Institute|June 19, 1991
Poor funding rates of cancer clinical research: intractable problem or solvable challenge?M A Friedman, D F Cain, D Bronzert, et al.
Biochemical Pharmacology|September 1, 1970
Effects of methylenedioxyphenyl insecticidal synergists in vitro on hydroxylations of biphenyl by mouse liver microsomesS S Epstein, R G Csillag, H Guerin, et al.
The British Journal of Surgery|May 1, 1989
Adjuvant multimodality treatment of rectal cancerD J Galloway, A M Cohen, B Shank, et al.
Cancer Treatment Reviews|September 1, 1986
Differentiating agents in the treatment of human malignanciesB D Cheson, D M Jasperse, H G Chun, et al.
Mutation Research|November 1, 1979
In vitro mutagenicity and cell-transformation screening of N-(2,3-epoxy-propyl)-phthalimideE J Greene, M A Friedman, J A Sherrod, et al.
Journal of Toxicology and Environmental Health|January 1, 1980
Tissue distribution and excretion of 2,4-[14C]toluenediamine in the mouseP D Unger, A J Salerno, W C Ness, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexateP A Volberding, M A Friedman, K J Resser, et al.
Cancer|April 15, 1981
Abscess formation in recurrent liposarcomas of the abdomen and retroperitoneum: relevance to treatmentM A Friedman, B G Orrok, A A Moss, et al.
Toxicology and Applied Pharmacology|October 1, 1979
Acute toxicity of N-(2,3-epoxy-propyl)-phthalimideE J Greene, M A Friedman, M A Gallo, et al.
Addictive Behaviors|May 1, 1997
Self-directed hostility and family functioning in normal-weight bulimics and overweight binge eatersM A Friedman, D E Wilfley, R R Welch, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Journal of the National Cancer Institute|June 19, 1991
Poor funding rates of cancer clinical research: intractable problem or solvable challenge?M A Friedman, D F Cain, D Bronzert, et al.
Biochemical Pharmacology|September 1, 1970
Effects of methylenedioxyphenyl insecticidal synergists in vitro on hydroxylations of biphenyl by mouse liver microsomesS S Epstein, R G Csillag, H Guerin, et al.
The British Journal of Surgery|May 1, 1989
Adjuvant multimodality treatment of rectal cancerD J Galloway, A M Cohen, B Shank, et al.
Cancer Treatment Reviews|September 1, 1986
Differentiating agents in the treatment of human malignanciesB D Cheson, D M Jasperse, H G Chun, et al.
Mutation Research|November 1, 1979
In vitro mutagenicity and cell-transformation screening of N-(2,3-epoxy-propyl)-phthalimideE J Greene, M A Friedman, J A Sherrod, et al.
Journal of Toxicology and Environmental Health|January 1, 1980
Tissue distribution and excretion of 2,4-[14C]toluenediamine in the mouseP D Unger, A J Salerno, W C Ness, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexateP A Volberding, M A Friedman, K J Resser, et al.
Cancer|April 15, 1981
Abscess formation in recurrent liposarcomas of the abdomen and retroperitoneum: relevance to treatmentM A Friedman, B G Orrok, A A Moss, et al.
Toxicology and Applied Pharmacology|October 1, 1979
Acute toxicity of N-(2,3-epoxy-propyl)-phthalimideE J Greene, M A Friedman, M A Gallo, et al.
Addictive Behaviors|May 1, 1997
Self-directed hostility and family functioning in normal-weight bulimics and overweight binge eatersM A Friedman, D E Wilfley, R R Welch, et al.
Pageof 22